Castle Biosciences, Inc. (CSTL) Tops Q3 Earnings and Revenue Estimates

Castle Biosciences, Inc. (CSTL) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of a loss of $0.06 per share. This compares to loss of $0.26 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 233.33%. A quarter ago, it was expected that this company would post a loss of $0.16 per share when it actually produced earnings of $0.31, delivering a surprise of 293.75%.Over the last four quarter ...